Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI

1. Treace Medical Concepts faces a class action lawsuit for alleged securities fraud. 2. Lawsuit claims false statements about company revenues and product success. 3. Investors have until June 10, 2025, to act as lead plaintiffs. 4. Past performance of Levi & Korsinsky indicates strong potential for recovery. 5. Compensation may be available to affected investors without upfront costs.

Legal

75

4m saved

Insight

Article

FAQ

Why Very Bearish?

The class action lawsuit can significantly undermine investor confidence and adversely affect TMCI's stock price, similar to past instances where legal troubles led to steep declines in affected stocks. For example, stocks like Teva Pharmaceutical (TEVA) faced substantial drops during similar legal proceedings.

How important is it?

The lawsuit highlights potential fraud and operational challenges, directly impacting TMCI's perceived value among investors. Legal issues in the corporate landscape tend to attract significant media scrutiny, affecting market sentiments and stock values.

Why Short Term?

Immediate legal troubles may lead to a quicker reaction in stock price, while ongoing litigation could impact longer-term perceptions of the company. Immediate investor reactions to lawsuits often result in volatile short-term stock price movements.

Related Companies

TEVA MDU LQDT

NEW YORK, April 29, 2025

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.

CLASS DEFINITION:

The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=145736&wire=4

TMCI investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS:

The filed complaint alleges that defendants made false statements and/or concealed that: (1) competition impacted the demand for and utilization of its primary product, the 3D bunion correction system, the "Lapiplasty"; (2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT'S NEXT?

If you suffered a loss in Treace Medical Concepts, Inc. during the relevant time frame, you have until June 10, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU:

If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY:

Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP